- RNA sequencing (RNA-seq) is a high-throughput sequencing technology used to investigate gene expression, transcript abundance, alternative splicing, transcript structure, and other aspects of RNA biology. It provides a comprehensive view of the transcriptome by sequencing RNA-derived complementary DNA (cDNA) or, in some protocols, RNA molecules directly. RNA-seq is widely used in gene expression studies, disease research, functional genomics, developmental biology, microbiology, and animal breeding. However, RNA-seq measurements are affected by several biological, experimental, and computational biases. Understanding these biases is essential for interpreting results accurately and avoiding misleading biological conclusions.
- RNA-seq bias refers to any systematic factor that causes the observed sequencing data to differ from the underlying biological RNA population. These biases can arise during sample collection, RNA extraction, RNA enrichment, library preparation, amplification, sequencing, read alignment, and computational analysis. Some biases affect the representation of particular transcripts, while others influence the estimated expression levels, detection of alternative isoforms, or identification of differential gene expression. Because RNA-seq is a multistep experimental and computational process, errors introduced at an early stage may influence all subsequent analyses.
- RNA quality and degradation are important sources of bias. RNA molecules can degrade during sample collection, storage, transportation, or extraction, particularly when samples are exposed to unsuitable temperatures or RNase enzymes. Degradation may cause uneven transcript coverage, loss of transcript regions, and underrepresentation of particular RNA species. RNA integrity is commonly assessed using the RNA Integrity Number (RIN) or related measurements. Poor-quality RNA can reduce the reliability of gene expression estimates and make comparisons between samples difficult. Consistent sample handling, rapid stabilization, appropriate storage, and RNA quality assessment help reduce this problem.
- RNA selection and enrichment methods introduce another important source of bias. Poly(A) selection enriches messenger RNAs containing polyadenylated tails, making it useful for studying protein-coding gene expression. However, it may exclude non-polyadenylated transcripts, including many non-coding RNAs, histone transcripts, and some degraded or incompletely processed RNA molecules. Ribosomal RNA (rRNA) depletion removes abundant ribosomal RNA and allows the analysis of a broader range of RNA species, including many non-coding and partially processed transcripts. However, depletion efficiency can vary, and residual rRNA may consume sequencing capacity. The choice between poly(A) selection and rRNA depletion should therefore depend on the biological objectives and RNA types being investigated.
- Library preparation can introduce sequence-dependent and transcript-dependent biases. During fragmentation, RNA or cDNA molecules may be broken into fragments of different sizes, affecting the representation of transcript regions. Reverse transcription converts RNA into cDNA, but reverse transcriptase enzymes may differ in their efficiency across sequences and RNA structures. Highly structured RNA regions, extreme GC content, and transcript length can influence cDNA synthesis. PCR amplification may further distort transcript representation because some fragments amplify more efficiently than others. Excessive PCR amplification can also produce duplicate reads and increase technical variation. Using appropriate library preparation protocols, minimizing unnecessary amplification, and applying consistent procedures across samples can reduce these effects.
- GC-content bias occurs when sequencing or library preparation processes favor fragments with particular proportions of guanine (G) and cytosine (C). Regions with very high or very low GC content may be underrepresented because of differences in amplification efficiency, cluster generation, or sequencing performance. This can lead to inaccurate expression estimates for genes with unusual GC composition. GC-content distribution is commonly examined during quality control using tools such as FastQC and MultiQC. Computational normalization and correction methods may help address some GC-related effects, although they cannot fully recover transcripts that were not represented in the library.
- Transcript length bias is another important consideration, particularly when comparing expression estimates across genes. Longer transcripts may generate more sequencing fragments than shorter transcripts when their abundance is equal. Measures such as fragments per kilobase of transcript per million mapped reads (FPKM) and transcripts per million (TPM) account for transcript length and sequencing depth in different ways. However, length-normalized values are not automatically suitable for every statistical comparison. Differential gene expression analysis generally uses raw read or fragment counts with statistical models that account for library size and biological variability. Length normalization is more commonly used when describing transcript abundance within a sample.
- Sequencing depth and coverage influence the ability to detect transcripts and quantify their expression. Low sequencing depth may fail to detect rare transcripts, weakly expressed genes, or low-frequency splice variants. Increasing sequencing depth improves the probability of detecting low-abundance transcripts, but the benefits eventually diminish as additional reads provide less new information. Coverage bias can also occur when reads are unevenly distributed across transcripts. Sequencing depth should therefore be selected according to the research objective, expected transcript abundance, sample complexity, and need to detect alternative splicing or rare transcripts.
- Mapping bias occurs when sequencing reads are aligned to a reference genome or transcriptome. Reads from repetitive regions, paralogous genes, pseudogenes, and highly similar transcript isoforms may map to multiple locations or fail to map correctly. Reference genomes may also differ from the genetic background of the studied population, causing reads containing polymorphisms or structural variations to align less efficiently. This can result in allele-specific mapping bias, where reads from one allele are preferentially mapped while reads from another allele are underrepresented. Splice-aware aligners such as STAR and HISAT2 are commonly used for RNA-seq alignment, while tools such as Salmon and kallisto support transcript-level quantification using lightweight or quasi-mapping approaches. Mapping quality, multimapping reads, reference quality, and annotation completeness must be considered during interpretation.
- PCR duplicates and optical duplicates can also affect RNA-seq results. PCR duplicates arise when the same original cDNA fragment is amplified multiple times, whereas optical duplicates can originate from sequencing instrument imaging and cluster detection. Duplicate reads may inflate apparent coverage and distort abundance estimates, particularly in libraries with low input material or extensive amplification. Tools such as Picard MarkDuplicates and samtools can help identify or manage duplicates. However, duplicate removal should be applied carefully because highly expressed transcripts can naturally produce many identical fragments, especially in experiments without unique molecular identifiers (UMIs). UMIs help distinguish original molecules from amplification duplicates and can improve molecule-level quantification.
- Biological variation is distinct from technical bias but is equally important for RNA-seq interpretation. Gene expression can vary among individuals, tissues, developmental stages, cell types, environmental conditions, and physiological states. Technical replicates measure variation associated with experimental procedures, whereas biological replicates represent independent biological samples and capture natural biological variability. An analysis based on insufficient biological replication may produce unstable estimates and unreliable statistical conclusions. Appropriate experimental design, randomization, balanced sample groups, and sufficient biological replication are therefore essential.
- Batch effects occur when samples are processed at different times, by different technicians, using different reagent lots, sequencing runs, or laboratory equipment. These technical differences can create systematic expression patterns unrelated to the biological condition under investigation. Principal component analysis (PCA), sample correlation analysis, hierarchical clustering, and expression distribution plots can help identify potential batch effects. Statistical models can incorporate known batch variables as covariates, while methods such as ComBat, limma, and surrogate variable analysis may help address unwanted variation. However, batch correction cannot reliably separate biological effects from technical effects when they are completely confounded. Balanced experimental design is therefore more effective than relying only on computational correction.
- Normalization is necessary because RNA-seq libraries often differ in sequencing depth and RNA composition. A sample containing a few extremely abundant transcripts may have fewer reads available for other genes, even when the total number of sequenced reads is similar. Methods such as DESeq2 median-of-ratios normalization and edgeR trimmed mean of M-values (TMM) estimate scaling factors to improve comparisons between samples. TPM is useful for describing relative transcript abundance within a sample, while raw counts combined with appropriate normalization factors are generally preferred for differential expression statistical testing. Normalization does not remove every technical bias, and its assumptions should be evaluated when studying large global changes in RNA abundance.
- RNA-seq interpretation also requires careful consideration of gene-level and transcript-level measurements. Gene-level analysis combines reads assigned to different transcripts from the same gene, providing an overall estimate of gene expression. Transcript-level analysis attempts to quantify individual isoforms and can reveal changes in alternative splicing, transcript usage, and isoform switching. However, short sequencing reads may not contain sufficient information to distinguish highly similar isoforms. Transcript quantification tools such as Salmon, kallisto, RSEM, and StringTie can estimate transcript abundance, but results depend on read length, sequencing depth, transcript annotation, and the complexity of the transcriptome. Long-read sequencing can provide additional information about complete transcript structures.
- Differential expression analysis identifies genes whose expression levels differ between experimental conditions. Tools such as DESeq2, edgeR, and limma-voom use statistical models to account for sequencing depth and biological variability. These methods typically estimate fold changes, calculate statistical significance, and adjust p-values for multiple hypothesis testing. The adjusted p-value, often based on the false discovery rate (FDR), helps control the expected proportion of false discoveries among significant results. A statistically significant result should not automatically be interpreted as biologically important. Effect size, expression level, experimental design, biological function, and independent validation should also be considered.
- Several quality-control tools support the identification of RNA-seq biases. FastQC examines read quality, sequence composition, GC content, adapter contamination, and duplication levels. MultiQC summarizes quality-control reports across multiple samples. Cutadapt and fastp remove adapter sequences and low-quality bases. STAR and HISAT2 perform splice-aware read alignment, while featureCounts and HTSeq-count generate gene-level read counts. Salmon, kallisto, and RSEM support transcript quantification. DESeq2, edgeR, and limma-voom are widely used for differential expression analysis. RSeQC provides additional assessments of RNA-seq library characteristics, including gene-body coverage, read distribution, and strand specificity.
- The interpretation of RNA-seq data must also account for the biological context of the samples. Bulk RNA-seq measures RNA from a mixture of cells, meaning that differences in gene expression may reflect changes in cell-type proportions rather than altered expression within individual cells. For example, an increase in immune-related transcripts in diseased tissue may result from immune-cell infiltration rather than increased expression in the original tissue cells. Single-cell RNA sequencing (scRNA-seq) can help resolve cell-specific expression patterns, although it introduces its own technical challenges, including dropout events, ambient RNA contamination, and differences in capture efficiency. Spatial transcriptomics provides additional information about the location of gene expression within tissues.
- In animal genomics and breeding, RNA-seq biases and their interpretation are particularly important when investigating genetic variation associated with economically important traits. Differences in gene expression may be related to growth, feed efficiency, milk production, meat quality, egg production, fertility, disease resistance, muscle development, and environmental adaptation. However, apparent expression differences may also result from tissue composition, age, sex, nutritional status, management conditions, stress, or sample-processing differences. Combining RNA-seq with genomic data, quantitative genetics, phenotypic measurements, and appropriate statistical models can help distinguish genuine biological relationships from technical artifacts. This integrated approach can support the identification of candidate genes, regulatory pathways, and potential molecular biomarkers for animal breeding.
- Reliable RNA-seq interpretation requires distinguishing technical artifacts, biological variation, and genuine molecular responses. No single quality-control or normalization method can eliminate every source of bias. Researchers should therefore evaluate sample quality, library characteristics, sequencing performance, mapping statistics, experimental design, normalization assumptions, and statistical results together. Independent validation using quantitative PCR (qPCR), digital PCR, protein analysis, or other functional experiments can strengthen important findings. Transparent reporting of sample preparation, sequencing protocols, quality-control procedures, reference genomes, software versions, and statistical methods is essential for reproducibility.
- RNA-seq biases and interpretation are fundamental topics in bioinformatics because sequencing data represent a combination of biological signals and technical influences. A clear understanding of these factors helps researchers avoid false conclusions, improve the reliability of differential expression analysis, and identify meaningful changes in gene regulation and transcript processing. As sequencing technologies, computational methods, and statistical models continue to advance, careful bias assessment will remain essential for transcriptomics, clinical research, functional genomics, and animal breeding.